Want to see TARA full AI Analyst Report?
Protara Therapeutics (TARA) Income Statement
Protara Therapeutics Income Statement
Last quarter (Q2 2026), Protara Therapeutics's total revenue was $0.00. In Q2, Protara Therapeutics's net income was $-21.67M. See Protara Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -362.00K | $ 0.00 | $ -341.00K | $ 0.00 | $ 0.00 | |
| $ 64.19M | $ 49.15M | $ 43.27M | $ 67.06M | $ 47.49M | |
| Depreciation and Amortization | $ 362.00K | $ 332.00K | $ 341.00K | $ 248.00K | $ 117.00K |
| $ -57.08M | $ -44.26M | $ -40.08M | $ -64.57M | $ -45.40M | |
| $ -64.55M | $ -49.15M | $ -43.61M | $ -67.06M | $ -47.49M | |
| $ 7.11M | $ 4.56M | $ 3.19M | $ 1.11M | $ 237.00K | |
| $ -57.44M | $ -44.60M | $ -40.42M | $ -65.95M | $ -47.25M | |
| $ -57.44M | $ -44.60M | $ -40.42M | $ -65.95M | $ -47.25M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.34 | $ -2.17 | $ -3.57 | $ -5.86 | $ -4.20 |
| Diluted EPS | $ -1.34 | $ -2.17 | $ -3.57 | $ -5.86 | $ -4.20 |
| Weighted Average Shares Outstanding | 42.84M | 20.59M | 11.33M | 11.26M | 11.23M |
| Weighted Average Shares Outstanding (Diluted) | 42.84M | 20.59M | 11.33M | 11.26M | 11.23M |
Currency in USD
